E-LIB Suche - Ergebnisse für: Yukari Okubo

1

Bimekizumab Safety and Tolerability in Moderate to Severe P..:

Gordon, Kenneth ; Thaçi, Diamant ; Gooderham, Melinda...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 4 - p. s404 , 2024

Link: https://doi.org/10.25251..

2

A case of anaphylaxis after ingestion of Enokitake (Flammul..:

Minami, Yoshihito ; Kanzaki, Mirei ; Egusa, Chizu...
The Journal of Dermatology. , 2024

Link: https://doi.org/10.1111/..

3

Consistent Efficacy of Apremilast in Patients with Psoriasi..:

Abe, Masatoshi ; Okubo, Yukari ; Takahashi, Hidetoshi...
Dermatology and Therapy. 14 (2024) 6 - p. 1587-1597 , 2024

Link: https://doi.org/10.1007/..

4

Safety and effectiveness of apremilast in Japanese patients..:

Ohtsuki, Mamitaro ; Okubo, Yukari ; Saeki, Hidehisa...
The Journal of Dermatology. 51 (2024) 7 - p. 950-963 , 2024

Link: https://doi.org/10.1111/..

5

Orofacial granulomatosis associated with indium allergy and..:

Yoshida, Kaoruko ; Numata, Takafumi ; Sugisaki, Risa...
The Journal of Dermatology. , 2024

Link: https://doi.org/10.1111/..

6

Deucravacitinib, an oral, selective, allosteric tyrosine ki..:

Imafuku, Shinichi ; Okubo, Yukari ; Tada, Yayoi...
The Journal of Dermatology. 51 (2024) 3 - p. 365-379 , 2024

Link: https://doi.org/10.1111/..

7

Bimekizumab 3-year Safety and Tolerability in Moderate to S..:

Lebwohl, Mark ; Strober, Bruce ; Langley, Richard G....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s305 , 2024

Link: https://doi.org/10.25251..

8

Efficacy and Safety of Brodalumab, an Anti-interleukin-17 R..:

Okubo, Yukari ; Kobayashi, Satomi ; Murakami, Masamoto...
American Journal of Clinical Dermatology. , 2024

Link: https://doi.org/10.1007/..

9

Exploratory Efficacy Evaluation of Apremilast for the Treat..:

Okubo, Yukari ; Terui, Tadashi ; Kobayashi, Satomi...
Dermatology and Therapy. 14 (2024) 7 - p. 1863-1873 , 2024

Link: https://doi.org/10.1007/..

10

Paediatric pustulotic arthro‐osteitis patient with an IL36R..:

Takami, Kenji ; Tsuji, Shigeyoshi ; Jokoji, Ryu..
Experimental Dermatology. 33 (2024) 1 - p. , 2024

Link: https://doi.org/10.1111/..

11

Deucravacitinib in plaque psoriasis: 2-year laboratory resu..:

Korman, Neil J. ; Passeron, Thierry ; Gordon, Kenneth B....
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s119 , 2023

Link: https://doi.org/10.25251..

12

Assessment of flare frequency and severity of generalized p..:

Morita, Akimichi ; Okubo, Yukari ; Imafuku, Shinichi...
JEADV Clinical Practice. 2 (2023) 2 - p. 261-272 , 2023

Link: https://doi.org/10.1002/..

13

Efficacy and Safety of Apremilast for the Treatment of Japa..:

Terui, Tadashi ; Okubo, Yukari ; Kobayashi, Satomi...
American Journal of Clinical Dermatology. 24 (2023) 5 - p. 837-847 , 2023

Link: https://doi.org/10.1007/..

14

Efficacy of spesolimab for the treatment of GPP flares acro..:

Burden, David ; Okubo, Yukari ; Zheng, Min...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s121 , 2023

Link: https://doi.org/10.25251..

15

Author Correction: Efficacy and Safety of Apremilast for th..:

Terui, Tadashi ; Okubo, Yukari ; Kobayashi, Satomi...
American Journal of Clinical Dermatology. 25 (2023) 1 - p. 165-167 , 2023

Link: https://doi.org/10.1007/..